October 12, 2015
The awarding ceremony was held in Basel, during the scientific symposium of the Swiss Group for Clinical Research on Cancer (SAKK), as part of the annual Congress of German companies, Austrian and Swiss Haematology and Medical Oncology.
The laureate for 2015 was: brentuximab védotine (ADCETRIS®, TAKEDA PHARMA).
For more information please contact Dr. Theo Constanda, mtconstanda@medical-tribune.ch
09/02/2016
